)
Alignment Healthcare (ALHC) investor relations material
Alignment Healthcare Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue rose 36.7% YoY to $1,358.3M and membership grew 31.2% to 301,200; higher-than-expected medical costs pressured profitability and prompted lower FY26 profit guidance.
Net loss was $8.1M versus net income of $3.7M a year earlier; Adjusted EBITDA was $21.8M, down 32.8% YoY.
Management expects at least 20% growth in 2027 and is pursuing claims, clinical and Stars improvements; revised guidance assumes no benefit from actions underway.
Financial highlights
Q3 total revenue was $1,358.3M, up 36.7% YoY; earned premiums were $1,348.3M.
Adjusted gross profit was $142.2M, up 11.6% YoY; adjusted EBITDA was $21.8M, down 32.8%.
Medical expenses rose 40.3% YoY to $1.218B, driven by membership growth and higher-than-expected medical cost trends in certain categories.
GAAP operating loss was $3.8M versus operating income of $7.7M; net loss was $8.1M versus net income of $3.7M.
Nine-month revenue increased 33.8% to $3,929.1M and net income rose to $39.9M from $10.0M.
Outlook and guidance
Q4 guidance: membership ≥305,000, revenue $1,316M, adjusted gross profit $104M and adjusted EBITDA loss of $28M; the gross-profit floor implies 92.1% MBR.
FY26 guidance: membership ≥305,000, revenue $5,245M, adjusted gross profit $575M and adjusted EBITDA $100M.
FY26 membership and revenue guidance increased, while adjusted gross profit and adjusted EBITDA guidance decreased due to higher Q3 medical costs.
Q4 assumptions include elevated claims, appeals and disputes at peak levels and typical seasonality; no offsets from initiatives are assumed, though their costs are included.
Management expects at least 20% growth in 2027, with a more balanced HMO mix; bids were reviewed market-by-market and product-by-product, with selective growth adjustments.
- Transformation nearly complete, setting up for scalable growth and long-term margin improvement.ALHC
2026 Global Healthcare Conference - Q2 2026 revenue and membership surged over 31%, driving raised full-year guidance.ALHC
Q2 2026 - Data-driven care and operational discipline fuel growth, with stable outlook and expanding markets.ALHC
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Stable trends, tech-driven growth, and expanding margins drive strong outlook and scalability.ALHC
Bank of America Global Healthcare Conference 2026 - Leadership structure updated with new Chair, Vice Chair, and executive appointments.ALHC
Proxy filing - Revenue up 33%, net income positive, and margin expansion drives strong Q1 results.ALHC
Q1 2026 - Board recommends approval of all proposals amid strong growth, governance, and ESG focus.ALHC
Proxy filing - Q2 revenue rose 47% and membership 56%, with improved margins and raised 2024 guidance.ALHC
Q2 2024 - Q1 2025 revenue rose 47.5% with higher guidance, margin gains, and a CFO transition.ALHC
Q1 2025
)
)
)
)
)
)
)
)